USD 62.0
(-0.85%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 9.58 Million USD | 8.71% |
2022 | 8.81 Million USD | 33.63% |
2021 | 6.59 Million USD | 6.01% |
2020 | 6.22 Million USD | -10.0% |
2019 | 6.91 Million USD | 27.71% |
2018 | 5.41 Million USD | 3.22% |
2017 | 5.24 Million USD | 15.46% |
2016 | 4.54 Million USD | 8.25% |
2015 | 4.19 Million USD | -13.88% |
2014 | 4.87 Million USD | 3.57% |
2013 | 4.7 Million USD | 8.06% |
2012 | 4.35 Million USD | -13.03% |
2011 | 5 Million USD | 61.61% |
2010 | 3.09 Million USD | -9.1% |
2009 | 3.4 Million USD | 4.03% |
2008 | 3.27 Million USD | 3.87% |
2007 | 3.15 Million USD | 3.82% |
2006 | 3.03 Million USD | -8.11% |
2005 | 3.3 Million USD | 15.6% |
2004 | 2.85 Million USD | -12.52% |
2003 | 3.26 Million USD | -6.04% |
2002 | 3.47 Million USD | 7.08% |
2001 | 3.24 Million USD | 8.09% |
2000 | 3 Million USD | -5.8% |
1999 | 3.19 Million USD | -20.25% |
1998 | 4 Million USD | -31.03% |
1997 | 5.8 Million USD | 20.83% |
1996 | 4.8 Million USD | 45.45% |
1995 | 3.3 Million USD | 1550.0% |
1994 | 200 Thousand USD | -95.24% |
1993 | 4.2 Million USD | 0.0% |
1992 | 4.2 Million USD | 0.0% |
1991 | 4.2 Million USD | 20.0% |
1990 | 3.5 Million USD | 25.0% |
1989 | 2.8 Million USD | 47.37% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 9.24 Million USD | -3.57% |
2024 Q3 | 9.1 Million USD | 0.54% |
2024 Q2 | 9.05 Million USD | -1.97% |
2023 Q2 | 10.11 Million USD | 1.79% |
2023 Q4 | 9.58 Million USD | -1.31% |
2023 Q3 | 9.7 Million USD | -4.04% |
2023 Q1 | 9.94 Million USD | 12.78% |
2023 FY | 9.58 Million USD | 8.71% |
2022 Q3 | 8.31 Million USD | 13.25% |
2022 Q1 | 7.36 Million USD | 11.69% |
2022 FY | 8.81 Million USD | 33.63% |
2022 Q4 | 8.81 Million USD | 6.06% |
2022 Q2 | 7.33 Million USD | -0.39% |
2021 Q1 | 5.97 Million USD | -3.97% |
2021 Q2 | 6.11 Million USD | 2.39% |
2021 Q4 | 6.59 Million USD | 4.72% |
2021 FY | 6.59 Million USD | 6.01% |
2021 Q3 | 6.29 Million USD | 2.96% |
2020 FY | 6.22 Million USD | -10.0% |
2020 Q1 | 6.75 Million USD | -2.26% |
2020 Q2 | 6.58 Million USD | -2.62% |
2020 Q3 | 6.3 Million USD | -4.19% |
2020 Q4 | 6.22 Million USD | -1.3% |
2019 Q3 | 6.71 Million USD | -12.98% |
2019 Q2 | 7.71 Million USD | 0.84% |
2019 Q1 | 7.64 Million USD | 41.29% |
2019 FY | 6.91 Million USD | 27.71% |
2019 Q4 | 6.91 Million USD | 3.01% |
2018 Q2 | 5.22 Million USD | -5.95% |
2018 Q4 | 5.41 Million USD | 10.02% |
2018 Q3 | 4.92 Million USD | -5.89% |
2018 FY | 5.41 Million USD | 3.22% |
2018 Q1 | 5.55 Million USD | 6.01% |
2017 Q1 | 4.76 Million USD | 4.89% |
2017 FY | 5.24 Million USD | 15.46% |
2017 Q4 | 5.24 Million USD | 4.01% |
2017 Q3 | 5.04 Million USD | 5.09% |
2017 Q2 | 4.79 Million USD | 0.71% |
2016 Q2 | 4.1 Million USD | -8.66% |
2016 Q3 | 4.52 Million USD | 10.38% |
2016 Q4 | 4.54 Million USD | 0.29% |
2016 Q1 | 4.49 Million USD | 7.05% |
2016 FY | 4.54 Million USD | 8.25% |
2015 Q2 | 4.47 Million USD | -7.77% |
2015 FY | 4.19 Million USD | -13.88% |
2015 Q1 | 4.85 Million USD | -0.45% |
2015 Q4 | 4.19 Million USD | -5.69% |
2015 Q3 | 4.44 Million USD | -0.54% |
2014 FY | 4.87 Million USD | 3.57% |
2014 Q4 | 4.87 Million USD | 0.02% |
2014 Q2 | 5.3 Million USD | 0.17% |
2014 Q1 | 5.29 Million USD | 12.5% |
2014 Q3 | 4.87 Million USD | -8.11% |
2013 FY | 4.7 Million USD | 8.06% |
2013 Q3 | 4.66 Million USD | 6.71% |
2013 Q2 | 4.36 Million USD | -0.89% |
2013 Q1 | 4.4 Million USD | 1.22% |
2013 Q4 | 4.7 Million USD | 0.94% |
2012 Q2 | 4.83 Million USD | -0.02% |
2012 FY | 4.35 Million USD | -13.03% |
2012 Q3 | 4.7 Million USD | -2.63% |
2012 Q1 | 4.83 Million USD | -3.4% |
2012 Q4 | 4.35 Million USD | -7.52% |
2011 Q4 | 5 Million USD | 0.85% |
2011 Q3 | 4.96 Million USD | -1.16% |
2011 FY | 5 Million USD | 61.61% |
2011 Q1 | 4.59 Million USD | 48.4% |
2011 Q2 | 5.02 Million USD | 9.25% |
2010 FY | 3.09 Million USD | -9.1% |
2010 Q1 | 3.37 Million USD | -1.09% |
2010 Q2 | 3.16 Million USD | -6.05% |
2010 Q3 | 3.27 Million USD | 3.28% |
2010 Q4 | 3.09 Million USD | -5.29% |
2009 Q1 | 3.7 Million USD | 13.07% |
2009 Q3 | 3.86 Million USD | -7.12% |
2009 Q4 | 3.4 Million USD | -11.78% |
2009 Q2 | 4.15 Million USD | 12.29% |
2009 FY | 3.4 Million USD | 4.03% |
2008 Q2 | 3.75 Million USD | 3.19% |
2008 FY | 3.27 Million USD | 3.87% |
2008 Q1 | 3.64 Million USD | 15.51% |
2008 Q3 | 3.61 Million USD | -3.81% |
2008 Q4 | 3.27 Million USD | -9.41% |
2007 Q4 | 3.15 Million USD | -7.78% |
2007 FY | 3.15 Million USD | 3.82% |
2007 Q2 | 3.23 Million USD | 0.84% |
2007 Q3 | 3.41 Million USD | 5.82% |
2007 Q1 | 3.2 Million USD | 5.5% |
2006 Q3 | 3.37 Million USD | 1.69% |
2006 Q1 | 3.47 Million USD | 4.99% |
2006 Q2 | 3.32 Million USD | -4.24% |
2006 Q4 | 3.03 Million USD | -10.12% |
2006 FY | 3.03 Million USD | -8.11% |
2005 Q2 | 2.65 Million USD | -6.56% |
2005 Q4 | 3.3 Million USD | 6.03% |
2005 FY | 3.3 Million USD | 15.6% |
2005 Q3 | 3.11 Million USD | 17.62% |
2005 Q1 | 2.83 Million USD | -0.8% |
2004 Q3 | 3.04 Million USD | -9.24% |
2004 Q4 | 2.85 Million USD | -6.14% |
2004 Q1 | 3.6 Million USD | 10.22% |
2004 FY | 2.85 Million USD | -12.52% |
2004 Q2 | 3.35 Million USD | -6.83% |
2003 FY | 3.26 Million USD | -6.04% |
2003 Q1 | 3.63 Million USD | 4.46% |
2003 Q2 | 3.86 Million USD | 6.3% |
2003 Q4 | 3.26 Million USD | -10.64% |
2003 Q3 | 3.65 Million USD | -5.31% |
2002 Q4 | 3.47 Million USD | 12.27% |
2002 FY | 3.47 Million USD | 7.08% |
2002 Q1 | 3.29 Million USD | 1.45% |
2002 Q2 | 3.35 Million USD | 1.7% |
2002 Q3 | 3.09 Million USD | -7.55% |
2001 Q1 | 3.11 Million USD | 3.66% |
2001 Q4 | 3.24 Million USD | -2.49% |
2001 Q3 | 3.33 Million USD | 6.22% |
2001 Q2 | 3.13 Million USD | 0.67% |
2001 FY | 3.24 Million USD | 8.09% |
2000 Q1 | 3.56 Million USD | 11.79% |
2000 Q4 | 3 Million USD | -7.08% |
2000 Q2 | 3.47 Million USD | -2.58% |
2000 FY | 3 Million USD | -5.8% |
2000 Q3 | 3.23 Million USD | -6.91% |
1999 Q4 | 3.19 Million USD | -3.33% |
1999 FY | 3.19 Million USD | -20.25% |
1999 Q2 | 3.3 Million USD | -13.16% |
1999 Q3 | 3.3 Million USD | 0.0% |
1999 Q1 | 3.8 Million USD | -5.0% |
1998 Q3 | 4.7 Million USD | 4.44% |
1998 Q4 | 4 Million USD | -14.89% |
1998 FY | 4 Million USD | -31.03% |
1998 Q2 | 4.5 Million USD | -16.67% |
1998 Q1 | 5.4 Million USD | -6.9% |
1997 FY | 5.8 Million USD | 20.83% |
1997 Q1 | 5.9 Million USD | 22.92% |
1997 Q2 | 6.4 Million USD | 8.47% |
1997 Q3 | 6.6 Million USD | 3.13% |
1997 Q4 | 5.8 Million USD | -12.12% |
1996 Q3 | 3.9 Million USD | -2.5% |
1996 Q2 | 4 Million USD | 11.11% |
1996 Q1 | 3.6 Million USD | 9.09% |
1996 Q4 | 4.8 Million USD | 23.08% |
1996 FY | 4.8 Million USD | 45.45% |
1995 Q4 | 3.3 Million USD | -10.81% |
1995 Q1 | 3.9 Million USD | 1850.0% |
1995 Q2 | 3.7 Million USD | -5.13% |
1995 Q3 | 3.7 Million USD | 0.0% |
1995 FY | 3.3 Million USD | 1550.0% |
1994 Q3 | 4.2 Million USD | -16.0% |
1994 Q4 | 200 Thousand USD | -95.24% |
1994 Q1 | 4.6 Million USD | 9.52% |
1994 FY | 200 Thousand USD | -95.24% |
1994 Q2 | 5 Million USD | 8.7% |
1993 Q3 | 3.9 Million USD | 0.0% |
1993 Q2 | 3.9 Million USD | 0.0% |
1993 Q1 | 3.9 Million USD | -7.14% |
1993 Q4 | 4.2 Million USD | 7.69% |
1993 FY | 4.2 Million USD | 0.0% |
1992 Q2 | 5.2 Million USD | 1.96% |
1992 Q1 | 5.1 Million USD | 21.43% |
1992 FY | 4.2 Million USD | 0.0% |
1992 Q4 | 4.2 Million USD | -6.67% |
1992 Q3 | 4.5 Million USD | -13.46% |
1991 Q1 | 3.7 Million USD | 5.71% |
1991 FY | 4.2 Million USD | 20.0% |
1991 Q2 | 3.9 Million USD | 5.41% |
1991 Q3 | 4 Million USD | 2.56% |
1991 Q4 | 4.2 Million USD | 5.0% |
1990 Q3 | 2.6 Million USD | 18.18% |
1990 Q4 | 3.5 Million USD | 34.62% |
1990 Q2 | 2.2 Million USD | -29.03% |
1990 Q1 | 3.1 Million USD | 10.71% |
1990 FY | 3.5 Million USD | 25.0% |
1989 FY | 2.8 Million USD | 47.37% |
1989 Q2 | 3 Million USD | 0.0% |
1989 Q3 | 2.7 Million USD | -10.0% |
1989 Q4 | 2.8 Million USD | 3.7% |
Name | Inventory | Inventory Difference |
---|---|---|
Akoya Biosciences, Inc. | 17.87 Million USD | 46.4% |
AngioDynamics, Inc. | 60.61 Million USD | 84.192% |
AtriCure, Inc. | 67.89 Million USD | 85.887% |
Avinger, Inc. | 5.29 Million USD | -80.861% |
Azenta, Inc. | 128.19 Million USD | 92.526% |
BioLife Solutions, Inc. | 43.45 Million USD | 77.95% |
The Cooper Companies, Inc. | 735.6 Million USD | 98.697% |
Daxor Corporation | - USD | -Infinity% |
Ekso Bionics Holdings, Inc. | 5.05 Million USD | -89.743% |
Femasys Inc. | 667.11 Thousand USD | -1336.328% |
GlucoTrack, Inc. | - USD | -Infinity% |
Harvard Bioscience, Inc. | 24.71 Million USD | 61.232% |
Hologic, Inc. | 679.8 Million USD | 98.59% |
ICU Medical, Inc. | 709.36 Million USD | 98.649% |
Intuitive Surgical, Inc. | 1.22 Billion USD | 99.215% |
KORU Medical Systems, Inc. | 3.48 Million USD | -175.242% |
LeMaitre Vascular, Inc. | 52.33 Million USD | 81.69% |
Innovative Eyewear, Inc. | 856.75 Thousand USD | -1018.401% |
Innovative Eyewear, Inc. | 856.75 Thousand USD | -1018.401% |
Masimo Corporation | 545 Million USD | 98.242% |
Microbot Medical Inc. | - USD | -Infinity% |
Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -492.496% |
Merit Medical Systems, Inc. | 303.87 Million USD | 96.847% |
Nephros, Inc. | 2.47 Million USD | -287.935% |
NovoCure Limited | 38.15 Million USD | 74.885% |
NEXGEL, Inc. | 1.31 Million USD | -626.459% |
NEXGEL, Inc. | 1.31 Million USD | -626.459% |
Singular Genomics Systems, Inc. | 13.57 Million USD | 29.399% |
OraSure Technologies, Inc. | 47.61 Million USD | 79.876% |
Pro-Dex, Inc. | 15.26 Million USD | 37.245% |
Pulse Biosciences, Inc. | - USD | -Infinity% |
Predictive Oncology Inc. | 494.37 Thousand USD | -1838.209% |
Precision Optics Corporation, Inc. | 2.86 Million USD | -234.089% |
QuidelOrtho Corporation | 577.8 Million USD | 98.342% |
Repligen Corporation | 202.32 Million USD | 95.264% |
Sanara MedTech Inc. | 4.71 Million USD | -103.115% |
STAAR Surgical Company | 35.13 Million USD | 72.724% |
Sharps Technology, Inc. | 1.7 Million USD | -460.634% |
DENTSPLY SIRONA Inc. | 624 Million USD | 98.464% |
Jin Medical International Ltd. | 5.05 Million USD | -89.625% |